切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2025, Vol. 14 ›› Issue (03) : 449 -455. doi: 10.3877/cma.j.issn.2095-3232.2025.03.018

临床研究

海德堡三角清扫在胰腺癌外科治疗中应用的系统评价
颜军1,2,3,4, 周强1,2,3,4, 郭诗翔1,2,3,4,()   
  1. 1. 400016 重庆医科大学
    2. 400714 中国科学院重庆绿色智能技术研究院
    3. 400714 中国科学院大学重庆学院
    4. 401147 重庆市人民医院肝胆胰腺外科研究所
  • 收稿日期:2024-07-29 出版日期:2025-06-10
  • 通信作者: 郭诗翔
  • 基金资助:
    国家自然科学基金(82373128)重庆英才计划-青年拔尖人才“包干制”项目(cstc2022ycjh-bgzxm0137)重庆市渝中区自然科学基金(20210160)

Systematic review of application of Heidelberg triangle dissection in surgical treatment of pancreatic cancer

Jun Yan1,2,3,4, Qiang Zhou1,2,3,4, Shixiang Guo1,2,3,4,()   

  1. 1. Chongqing Medical University,Chongqing 400016,China
    2. Chongqing Institute of Green and Intelligent Technology,Chinese Academy of Sciences,Chongqing 400714,China
    3. Chongqing School,University of Chinese Academy of Sciences,Chongqing 400714,China
    4. Institute of Hepatobiliary and Pancreatic Surgery,Chongqing People’s Hospital,Chongqing 401147,China
  • Received:2024-07-29 Published:2025-06-10
  • Corresponding author: Shixiang Guo
引用本文:

颜军, 周强, 郭诗翔. 海德堡三角清扫在胰腺癌外科治疗中应用的系统评价[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 449-455.

Jun Yan, Qiang Zhou, Shixiang Guo. Systematic review of application of Heidelberg triangle dissection in surgical treatment of pancreatic cancer[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2025, 14(03): 449-455.

目的

采用系统评价方法探讨海德堡三角清扫在胰腺癌外科治疗中的意义和临床应用价值。

方法

于2024年4月使用PubMed、Web of Science、Elsevier Journals、中国知网、维普、万方数据库进行计算机检索。英文数据库的检索式为:(“pancreatic cancer” OR “pancreatic neoplasm”) AND(“triangle “ OR “Heidelberg technique” OR “Heidelberg triangle”);中文数据库的检索式为:(胰腺癌OR胰腺肿瘤AND三角)。检索结果仅限于人类研究和中、英文论文。两位作者独立审查,选择文献。根据纽卡斯尔-渥太华量表(NOS)对文献质量评分。

结果

共检索2 152篇文献,最终4项回顾性队列研究纳入系统综述,文献NOS评分范围为6~8分。525例纳入研究,其中胰十二指肠切除术(PD)队列共327例,全胰切除术(TP)队列共114例,腹腔镜胰十二指肠切除术(LPD)84例。PD队列中海德堡组手术时间(556±46)min,明显长于标准组的(501±61)min(t=3.62,P<0.05);术后中位生存时间21个月,明显长于标准组的15个月(χ2=4.30,P<0.05);术后3年肿瘤复发率为55.56%,明显低于标准组的83.33%(P=0.040)。TP队列中海德堡组手术时间为434(385,490)min,明显长于标准组的367(315,445)min(P=0.0002);术中出血量为1 650(1 150,2 550)ml,明显多于标准组的800(500,1 500)ml(P<0.0001);R0切除率为30.8%,明显高于标准组的10.5%(P=0.0475)。LPD队列中海德堡组清扫淋巴结数目(11.31±2.46)枚,明显多于标准组的(9.49±2.28)枚(t=3.51,P<0.05);R0切除率为76.92%,明显高于标准组的53.33%(χ2=5.06,P=0.024)。

结论

海德堡三角清扫应用于胰腺癌外科治疗是安全可行的,可有效降低术后肿瘤复发率,延长患者生存时间。

Objective

To evaluate the significance and clinical application of Heidelberg triangle dissection in surgical treatment of pancreatic cancer by systematic review.

Methods

In April 2024, literature review was conducted from PubMed, Web of Science, Elsevier Journals, CNKI, Chongqing VIP and Wanfang databases using the key words: (“pancreatic cancer” OR “pancreatic neoplasm”) AND(“triangle” OR “Heidelberg technique” OR “Heidelberg triangle”) in English databases, and the key words:“ pancreatic cancer” OR “pancreatic neoplasm” AND “triangle”) in Chinese databases. The search results were limited to human research and articles in Chinese and English. Two authors independently reviewed and screened the literature. The quality of literatures was assessed by the Newcastle-Ottawa Scale (NOS).

Results

2 152 studies were retrieved, and 4 retrospective cohort studies were finally included in the systematic review. The NOS scores of the included studies were ranged from 6 to 8. 525 patients were included in this study, including 327 cases of pancreaticoduodenectomy (PD) cohorts, 114 cases of total pancreatectomy (TP) cohorts and 84 cases of laparoscopic pancreaticoduodenectomy (LPD). In the PD cohorts,the operation time in the Heidelberg tringle dissection group was (556±46) min, significantly longer than(501±61) min in the standard group (t=3.62, P<0.05). The median survival time after surgery was 21 months,significantly longer than 15 months in the standard group (χ2=4.30, P<0.05). The 3-year tumor recurrence rate was 55.56%, significantly lower than 83.33% in the standard group (P=0.040). In the TP cohorts, the operation time in the Heidelberg tringle dissection group was 434(385,490) min, significantly longer than 367(315,445) min in the standard group (P=0.0002). Intraoperative blood loss was 1 650(1 150,2 550) ml,significantly more than 800(500,1500) ml in the standard group (P<0.0001). The R0 resection rate was 30.8%, significantly higher than 10.5% in the standard group (P=0.0475). In the LPD cohorts, the number of dissected lymph nodes in the Heidelberg tringle dissection group was 11.31±2.46, significantly more than 9.49±2.28 in the standard group (t=3.51, P<0.05). The R0 resection rate was 76.92%, significantly higher than 53.33% in the standard group (χ2=5.06, P=0.024).

Conclusions

Heidelberg triangle dissection is safe and feasible in the surgical resection of pancreatic cancer, which can effectively reduce postoperative tumor recurrence rate and prolong the survival time of patients.

表1 海德堡三角清扫在胰腺癌外科治疗中应用系统评价的入组研究的特征
图1 海德堡三角清扫在胰腺癌外科治疗中应用系统评价的文献筛选流程图
[1]
Tonini V, Zanni M. Pancreatic cancer in 2021: what you need to know to win[J]. World J Gastroenterol, 2021, 27(35): 5851-5889. DOI:10.3748/wjg.v27.i35.5851.
[2]
Traub B, Link KH, Kornmann M. Curing pancreatic cancer[J].Semin Cancer Biol, 2021, 76: 232-246. DOI: 10.1016/j.semcancer.2021.05.030.
[3]
Strobel O, Neoptolemos J, Jäger D, et al. Optimizing the outcomes of pancreatic cancer surgery[J]. Nat Rev Clin Oncol, 2019, 16(1): 11-26.DOI: 10.1038/s41571-018-0112-1.
[4]
Gasparini G, Pellegatta M, Crippa S, et al. Nerves and pancreatic cancer: new insights into a dangerous relationship[J]. Cancers, 2019,11(7): 893. DOI: 10.3390/cancers11070893.
[5]
Verbeke CS, Gladhaug IP. Resection margin involvement and tumour origin in pancreatic head cancer[J]. Br J Surg, 2012, 99(8): 1036-1049. DOI: 10.1002/bjs.8734.
[6]
Butler JR, Ahmad SA, Katz MH, et al. A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma[J]. HPB, 2016, 18(4): 305-311. DOI: 10.1016/j.hpb.2015.11.009.
[7]
Groot VP, Rezaee N, Wu W, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma[J]. Ann Surg, 2018, 267(5): 936-945. DOI: 10.1097/SLA.0000000000002234.
[8]
Heye T, Zausig N, Klauss M, et al. CT diagnosis of recurrence after pancreatic cancer: is there a pattern?[J]. World J Gastroenterol, 2011,17(9): 1126-1134. DOI: 10.3748/wjg.v17.i9.1126.
[9]
吴鹏飞, 黄徐敏, 陈建敏, 等. 海德堡三角清扫在胰腺癌根治术中的应用价值[J]. 中华消化外科杂志, 2021, 20(4): 451-458. DOI:10.3760/cma.j.cn115610-20210308-00112.Wu PF, Huang XM, Chen JM, et al. Application value of TRIANGLE operation in radical resection of pancreatic cancer[J]. Chin J Dig Surg, 2021, 20(4): 451-458. DOI: 10.3760/cma.j.cn115610-20210308-00112.
[10]
Adham M, Singhirunnusorn J. Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors[J]. Eur J Surg Oncol, 2012, 38(4): 340-345. DOI: 10.1016/j.ejso.2011.12.015.
[11]
Hackert T, Strobel O, Michalski CW, et al. The TRIANGLE operation-radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study[J]. HPB, 2017,19(11): 1001-1007. DOI: 10.1016/j.hpb.2017.07.007.
[12]
Schneider M, Strobel O, Hackert T, et al. Pancreatic resection for cancer-the Heidelberg technique[J]. Langenbecks Arch Surg, 2019,404(8): 1017-1022. DOI: 10.1007/s00423-019-01839-1.
[13]
Klotz R, Hackert T, Heger P, et al. The TRIANGLE operation for pancreatic head and body cancers: early postoperative outcomes[J].HPB, 2022, 24(3): 332-341. DOI: 10.1016/j.hpb.2021.06.432.
[14]
Zhai S, Huo Z, Wang Y, et al. TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy[J]. Transl Cancer Res,2019,8(6):2416-2424. DOI: 10.21037/tcr.2019.09.50.
[15]
Rosso E, Zimmitti G, Iannelli A, et al. The ‘TRIANGLE operation’by laparoscopy: radical pancreaticoduodenectomy with major vascular resection for borderline resectable pancreatic head cancer[J].Ann Surg Oncol, 2020, 27(5): 1613-1614. DOI: 10.1245/s10434-019-08101-4.
[16]
Kauffmann EF, Napoli N, Ginesini M, et al. Feasibility of “cold”triangle robotic pancreatoduodenectomy[J]. Surg Endosc, 2022,36(12): 9424-9434. DOI: 10.1007/s00464-022-09411-7.
[17]
王振勇, 孟宇, 李金超, 等. 海德堡三角清扫在腹腔镜胰十二指肠切除术治疗胰腺癌中的近期疗效[J]. 中华胰腺病杂志, 2021,21(4): 282-286. DOI: 10.3760/cma.j.cn115667-20210202-00031.Wang ZY, Meng Y, Li JC, et al. Short-term outcome of Heidelberg triangle dissection in laparoscopic pancreaticoduodenectomy for pancreatic cancer[J]. Chin J Pancreatol, 2021, 21(4): 282-286. DOI:10.3760/cma.j.cn115667-20210202-00031.
[18]
黄孝伦, 邹海波, 赖春友, 等. 海德堡三角清扫胰十二指肠切除术治疗胰头癌的临床疗效[J]. 中华消化外科杂志, 2022, 21(4): 500-506. DOI: 10.3760/cma.j.cn115610-20220321-00147.Huang XL, Zou HB, Lai CY, et al. Clinical efficacy of pancreaticoduodenectomy with TRIANGLE operation in the treatment of pancreatic head cancer[J]. Chin J Dig Surg, 2022, 21(4):500-506. DOI: 10.3760/cma.j.cn115610-20220321-00147.
[19]
马东伟. 海德堡三角清扫胰十二指肠切除术在胰头癌治疗中的应用效果分析[J]. 中外医学研究, 2022, 20(27): 127-130. DOI:10.14033/j.cnki.cfmr.2022.27.033.Ma DW. Application effect analysis of Heidelberg triangle dissection pancreaticoduodenectomy for pancreatic head cancer[J]. Chin Foreign Med Res, 2022, 20(27): 127-130. DOI: 10.14033/j.cnki.cfmr.2022.27.033.
[20]
Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions[J]. Cochrane Database Syst Rev,2019, 10(10): ED000142. DOI: 10.1002/14651858.ED000142.
[21]
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses[J]. Eur J Epidemiol, 2010, 25(9): 603-605. DOI: 10.1007/s10654-010-9491-z.
[22]
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews[J].Int J Surg, 2021, 88: 105906. DOI: 10.1016/j.ijsu.2021.105906.
[23]
Hackert T, Büchler MW. Pancreatic cancer: advances in treatment,results and limitations[J]. Dig Dis, 2013, 31(1): 51-56. DOI:10.1159/000347178.
[24]
Khalaf N, El-Serag HB, Abrams HR, et al. Burden of pancreatic cancer: from epidemiology to practice[J]. Clin Gastroenterol Hepatol,2021, 19(5): 876-884. DOI: 10.1016/j.cgh.2020.02.054.
[25]
Ghaneh P, Kleeff J, Halloran CM, et al. The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma[J]. Ann Surg, 2019, 269(3): 520-529. DOI: 10.1097/SLA.0000000000002557.
[26]
Hartwig W, Gluth A, Hinz U, et al. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer[J]. Br J Surg, 2016, 103(12): 1683-1694.DOI: 10.1002/bjs.10221.
[27]
Ishikawa O, Ohhigashi H, Sasaki Y, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head[J]. Ann Surg, 1988, 208(2): 215-220. DOI:10.1097/00000658-198808000-00014.
[28]
Manabe T, Ohshio G, Baba N, et al. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas[J]. Cancer, 1989, 64(5):1132-1137. DOI: 10.1002/1097-0142(19890901)64:5<1132::aidcncr2820640528>3.0.co;2-v.
[29]
Dasari BVM, Pasquali S, Vohra RS, et al. Extended versus standard lymphadenectomy for pancreatic head cancer: meta-analysis of randomized controlled trials[J]. J Gastrointest Surg, 2015, 19(9):1725-1732. DOI: 10.1007/s11605-015-2859-3.
[30]
Orci LA, Meyer J, Combescure C, et al. A meta-analysis of extended versus standard lymphadenectomy in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma[J]. HPB,2015, 17(7): 565-572. DOI: 10.1111/hpb.12407.
[31]
国家卫生健康委办公厅. 胰腺癌诊疗指南(2022年版)[J]. 临床肝胆病杂志, 2022, 38(5): 1006-1015. DOI: 10.3969/j.issn.1001-5256.2022.05.007.General Office of National Health Commission.Standard for diagnosis and treatment of pancreatic cancer (2022 edition)[J]. J Clin Hepatol,2022, 38(5): 1006-1015. DOI: 10.3969/j.issn.1001-5256.2022.05.007.
[32]
Zureikat AH, Beane JD, Zenati MS, et al. 500 minimally invasive robotic pancreatoduodenectomies: one decade of optimizing performance[J]. Ann Surg, 2021, 273(5): 966-972. DOI: 10.1097/SLA.0000000000003550.
[33]
Rosemurgy A, Ross S, Bourdeau T, et al. Robotic pancreaticoduod-enectomy is the future: here and now[J]. J Am Coll Surg, 2019,228(4): 613-624. DOI: 10.1016/j.jamcollsurg.2018.12.040.
[34]
Shi Y, Jin J, Qiu W, et al. Short-term outcomes after robot-assisted vs open pancreaticoduodenectomy after the learning curve[J]. JAMA Surg, 2020, 155(5): 389-394. DOI: 10.1001/jamasurg.2020.0021.
[35]
Rebelo A, Büdeyri I, Heckler M, et al. Systematic review and metaanalysis of contemporary pancreas surgery with arterial resection[J].Langenbecks Arch Surg, 2020, 405(7): 903-919. DOI: 10.1007/s00423-020-01972-2.
[36]
Delpero JR, Jeune F, Bachellier P, et al. Prognostic value of resection margin involvement after pancreaticoduodenectomy for ductal adenocarcinoma: updates from a French prospective multicenter study[J]. Ann Surg, 2017, 266(5): 787-796. DOI: 10.1097/SLA.0000000000002432.
[37]
Ren L, Jäger C, Schorn S, et al. Arterial resection for pancreatic cancer: feasibility and current standing in a high-volume center[J]. Ann Surg Open, 2023, 4(3): e302. DOI: 10.1097/AS9.0000000000000302.
[38]
Loos M, Strobel O, Dietrich M, et al. Hyperamylasemia and acute pancreatitis after pancreatoduodenectomy: two different entities[J].Surgery, 2021, 169(2): 369-376. DOI: 10.1016/j.surg.2020.07.050.
[39]
Loos M, Kester T, Klaiber U, et al. Arterial resection in pancreatic cancer surgery: effective after a learning curve[J]. Ann Surg, 2022,275(4): 759-768. DOI: 10.1097/SLA.0000000000004054.
[40]
吴鹏飞, 蒋奎荣. 胰腺癌根治术中动脉切除相关问题[J]. 肝胆外科杂志, 2024, 32(2): 85-88, 92.Wu PF, Jiang KR. Problems related to arterial resection in radical resection of pancreatic cancer[J]. J Hepatobiliary Surg, 2024, 32(2):85-88, 92.
[41]
Inoue Y, Saiura A, Yoshioka R, et al. Pancreatoduodenectomy with systematic mesopancreas dissection using a supracolic anterior arteryfirst approach[J]. Ann Surg, 2015, 262(6): 1092-1101. DOI: 10.1097/SLA.0000000000001065.
[1] 刘伟博, 李林, 张玉斌. ERAS理念下的经脐单孔腹腔镜胆囊切除术对患者术后恢复的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 278-281.
[2] 李鹏, 刘光世, 李涛. 基于黑色素瘤相关抗原A6在胃癌转移与预后的作用机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 282-284.
[3] 董家旭, 宋美姿, 毕讯. 射频消融术联合TSH抑制治疗甲状腺微小乳头状癌的效果及生存预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 200-203.
[4] 杨培容, 潘刚, 周春霞. 胰腺癌术后胰瘘的危险因素及治疗进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 228-230.
[5] 陈宝鹤, 张文卓, 王隽. 头尾侧联合入路腹腔镜右半结肠癌根治术的近中期临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 153-156.
[6] 韦洋, 赵远权, 王小波, 黄海, 陈洁. BCLC 0/A期肝细胞癌患者术后辅助治疗后早期复发风险分析及预测模型建立[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 157-161.
[7] 郄云凯, 张哲, 梁山, 吴周亮, 李雨竹, 付晨辉, 沈冲, 胡海龙. 经尿道膀胱肿瘤整块切除术在T1期膀胱癌病理亚分期中的价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(03): 303-308.
[8] 龙朝辉, 陈丹, 王依杰, 瞿根义, 徐勇, 阳光, 黄文琳, 汤乘. 膀胱尿路上皮癌血管生成相关LncRNA预后评估模型的构建与分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(03): 315-322.
[9] 朱丹丹, 杨云, 胡忠, 韩明丽, 彭广艳, 郝钊. 类鼻疽菌感染重症肺炎临床特征及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(02): 289-294.
[10] 刘凯, 刘鹏炯, 李振琪, 冯晨, 曹雨, 胡明根, 刘荣. 机器人与开腹肝尾状叶肿瘤切除的对比研究[J/OL]. 中华腔镜外科杂志(电子版), 2025, 18(02): 90-97.
[11] 刘翔, 刘军桂, 张涛, 金奎, 郭宇, 雷磊, 段伟宏. 胰腺癌动脉受侵的类型及手术策略研究[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 442-448.
[12] 甘翌翔, 欧阳俐颖, 潘扬勋, 张耀军, 陈敏山, 徐立. ICGR15和ALBI评分对肝动脉灌注化疗后肝癌肝切除术后肝衰竭和预后的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 395-401.
[13] 毛伟民, 蓝祝晶, 徐邦浩, 朱海, 王继龙, 金宗睿, 蒙柄成, 卢婷婷, 曾晶晶, 吕自力, 宋瑞, 文张. 肝肉瘤样癌14例临床诊疗分析[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(03): 435-441.
[14] 朱锴, 李爽, 刘艳成, 张净宇, 张宏, 张洪亮, 刘金伟, 胡永成. 肾癌脊柱转移瘤手术疗效及预后因素分析报道:附系统综述[J/OL]. 中华老年骨科与康复电子杂志, 2025, 11(02): 87-101.
[15] 李政, 陆永刚, 杨轶婷, 聂升波, 刘敏杰, 杨勇, 季小娟, 樊健. 改良Henry入路保留旋前方肌内固定术对桡骨远端骨折患者手术疗效及远期预后的影响[J/OL]. 中华老年骨科与康复电子杂志, 2025, 11(02): 117-122.
阅读次数
全文


摘要